On Wednesday, the U.S. Food and Drug Administration will begin a two-day hearing into all-metal hip implants, examining reports that the devices are causing debilitating health problems for a large proportion of the patients who receive them.
A report on Boston.com says the all-metal implants – in which both the ball and sockets are coated with metal – were originally introduced ...
continue reading...According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal.
The report cites unnamed sources who said the settlement would be one of the highest ever in a drug marketing case.
Federal law says drug makers can market medicines only for uses approved by the U.S. ...
continue reading...
In a recent article, The Motley Fool writer Catherine Baab-Muguira addresses a number of recent management errors and product recalls at Johnson & Johnson.
She writes that they’ve “had investors scratching their heads and asking: Is Johnson & Johnson broken?”
The Department of Justice filed a civil False Claims Act against Johnson & Johnson in 2010, alleging that the company had illegally paid kickbacks to nursing-home pharmaceutical supplier Omnicare to induce Omnicare ...
continue reading...Johnson & Johnson officials hope the $19.7 billion acquisition of Synthes, which makes surgical trauma equipment and orthopedic implants, will give the company a dominant position in the orthopedic surgery market.
According to a Bloomberg report, Johnson & Johnson’s prescription drugs and consumer health segments have both suffered revenue losses in recent years following a series of recalls.
Johnson & Johnson has launched about two dozen recalls of nonprescription drugs and at ...
continue reading...
Bloomberg reports that Johnson & Johnson has agreed to pay as much as $2.2 billion to settle federal government investigations into claims that the company illegally marketed antipsychotic drug Risperdal and other medications.
The report quotes unnamed sources as saying the settlement will include a misdemeanor plea and a criminal penalty of as much as $600 million.
But that wouldn’t be the end of Johnson & Johnson’s legal troubles. The company is ...
continue reading...
A newspaper report warns New Zealanders to brace for another round of invasive surgery after a recall of more hip implants.
According to The Dominion Post, Smith & Nephew R3 hip implants were recalled after unusually high rates of replacement surgery were required in Australia and the United Kingdom.
The report mentions a similar recall of DePuy all-metal hip implants from 2010. ...
continue reading...
